Fintech PR
Jensen Partners Establishes Presence in Southwestern U.S. with New Office Location and Senior Appointment
Firm Unveils New Office and Managing Director in Austin, Texas
NEW YORK, July 31, 2023 /PRNewswire/ — Jensen Partners (“the Firm”), a leading global distribution-focused executive search and corporate advisory firm, today announced an important expansion with the opening of a new office in Austin, Texas and the appointment of Stacy Schiffman to Managing Director of Distribution. Schiffman, who recently assumed her new role and now leads Jensen Partners’ Austin office, is responsible for overseeing all aspects of search execution, including candidate generation and engagement, as well as client management and interview preparation, with a particular focus on investment and capital raising roles. Schiffman is also playing an integral role in driving the Firm’s business development outreach, research and market intelligence to help guide hiring decisions and foster greater client outcomes.
Austin is a burgeoning financial center home to major private markets participants in the Southwestern US. As Jensen Partners’ Austin office head, Schiffman is responsible for solidifying the Firm’s relationships with clients and candidates in the area, and her appointment marks the latest development in Jensen Partners’ global growth journey. In January 2023, the Firm announced the opening of a new office location in Miami, Florida to serve its growing list of clients who expanded their footprint in the region; and in October 2022, Jensen Partners announced a strategic investment from JB Capital to accelerate data integration and scale key product offerings that address a wider range of talent challenges including diversity, equity and inclusion (DEI), recruiting, hiring and retention.
“Stacy’s role in Austin is the latest step towards enhancing our Firm’s commitment to maintaining a strategic presence in major financial centers in both the U.S. and across the globe,” said Sasha Jensen, Founder and CEO of Jensen Partners and Jensen DiversityMetrics™. “Her decades of insight will help us continue to build deeper relationships with the best talent in the industry and further solidify our capacity to drive superior long-term human capital solutions for our clients globally. We are thrilled to welcome her to the team.”
Schiffman joins Jensen Partners from PIMCO, where she led marketing recruiting. Prior to PIMCO, she launched Highline Staffing, a firm that specialized in the recruitment and placement of capital raising and investment professionals for leading asset management firms globally. From 2005 to 2009, Schiffman was an institutional relationship manager for marketing and client management at Prisma Capital Partners, where she focused on business development and raising assets across strategies in the alternative investment industry. She was also involved with recruiting on the buyside, helping to expand global footprints. Schiffman began her career on the buyside with Sanford C. Bernstein, managing the firm’s esteemed research department.
“I’m excited to join such a dedicated and passionate group at Jensen Partners, whose unique vision and platform has solidified its place as the industry’s leading data-driven talent solutions resource,” said Schiffman. “Jensen Partners’ mission-driven and highly impactful integrated recruitment strategy has quickly become the gold standard in the alternative asset management space, and I look forward to contributing to the important work that Sasha and her team are doing.”
About Jensen Partners
Jensen Partners is a global advisory, corporate development and executive search firm that leverages its extensive relationships in the investor and alternative asset management community to source and recruit leading capital raising and investment candidates. The Firm takes a data-driven approach, combining quantitative and qualitative insights to source and place the ideal human capital. In addition to executive search, Jensen Partners offers LP/GP referencing, proprietary 360° Investor Referencing™ methodology, and compensation benchmarking and analysis. Known globally as a leader in the asset management space for its transformative talent and DEI solutions, Jensen Partners has been named one of the world’s most innovative companies with fewer than 100 employees by Fast Company; the “Best Recruiter” in Europe by Hedgeweek and Private Equity Wire; and the top DEI provider within Operations and Service by Fund Intelligence. To learn more, please visit www.jensen-partners.com.
About Jensen DiversityMetrics™
Jensen DiversityMetrics™ combines rich diversity analytics with the latest research from the field of human capital management, providing an objective, 360 degree view of where a firm stands on DEI and how they can make meaningful progress towards a more diverse, equitable and inclusive workforce, including: verified demographic data for more than 25,000 investment and distribution professionals from across the industry, a candidate pipeline of over 8,000 investment and distribution professionals who self-identify as having a diverse background and a proprietary scoring algorithm that enables objective DEI comparisons across firms and industries. With Jensen DiversityMetrics™, firms can benchmark against competitors, develop diverse candidate pipelines, analyze hiring and retention practices, identify biases in workplace culture and report progress to investors.
Jensen Partners publishes JensenDiversityMetrics™ data and insights in its quarterly newsletter. To sign up for Jensen Partners’ newsletters, please visit: https://lp.constantcontactpages.com/su/tbmquk0.
Media Contacts
Prosek Partners
Max Berger
[email protected]
215-595-3696
View original content:https://www.prnewswire.co.uk/news-releases/jensen-partners-establishes-presence-in-southwestern-us-with-new-office-location-and-senior-appointment-301889221.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
Clayfin Technologies and Jana Small Finance Bank Honored with Prestigious IBSi Digital Banking Award 2024
-
Latest News5 days ago
Trakx launches a new product: Trakx USDc Earn CTI powered by OpenTrade
-
Latest News6 days ago
HANDSHAKE SPEAKEASY IN MEXICO CITY NAMED AS THE BEST BAR IN NORTH AMERICA AS RANKING OF NORTH AMERICA’S 50 BEST BARS IS REVEALED AT THIRD ANNUAL AWARDS CEREMONY
-
Latest News6 days ago
SDAX Unveils World’s First Securitised Gold Tokens for Digital Exchange Users
-
Latest News6 days ago
BINGHATTI LAUNCHES ITS DEBUT PROJECT ADJACENT TO DUBAI HILLS
-
Latest News6 days ago
Venom Blockchain and United Network Forge Strategic Partnership to Power Next-Generation Payment Systems
-
Latest News5 days ago
Money20/20 Asia 2024: Days Two Roundup
-
Latest News6 days ago
Allfunds has partnered with Google Cloud to leverage AI-powered innovation and optimize its infrastructure.